Difficulty: Medium
Average Score: 75%
Practice
Which of the following medications is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin induced thrombocytopenia.
Correct answer
A
Rationale
Rationale:
The correct answer is A) Argatroban. Argatroban is a direct thrombin inhibitor that is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin-induced thrombocytopenia (HIT). Heparin-induced thrombocytopenia is an adverse reaction to heparin that causes a drop in platelet count and can lead to thrombosis. Argatroban works by directly inhibiting thrombin, an essential enzyme in the blood clotting process.
Option B) Fondaparinux is a factor Xa inhibitor and is not indicated for use in clients with HIT. Option C) Dabigatran is a direct thrombin inhibitor but is not the preferred choice for clients with HIT. Option D) Desirudin is another direct thrombin inhibitor, but Argatroban is the preferred agent for clients with HIT due to its shorter half-life and reversibility compared to Desirudin.
Educationally, understanding the different classes of anticoagulants and their indications is crucial for healthcare providers managing clients with thrombotic disorders. Recognizing the specific agents used in different scenarios, such as in clients with HIT, ensures appropriate and effective treatment strategies are implemented to prevent further complications. Argatroban's unique mechanism of action and suitability for clients with HIT make it a key medication to be aware of in hematological practice.
The correct answer is A) Argatroban. Argatroban is a direct thrombin inhibitor that is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin-induced thrombocytopenia (HIT). Heparin-induced thrombocytopenia is an adverse reaction to heparin that causes a drop in platelet count and can lead to thrombosis. Argatroban works by directly inhibiting thrombin, an essential enzyme in the blood clotting process.
Option B) Fondaparinux is a factor Xa inhibitor and is not indicated for use in clients with HIT. Option C) Dabigatran is a direct thrombin inhibitor but is not the preferred choice for clients with HIT. Option D) Desirudin is another direct thrombin inhibitor, but Argatroban is the preferred agent for clients with HIT due to its shorter half-life and reversibility compared to Desirudin.
Educationally, understanding the different classes of anticoagulants and their indications is crucial for healthcare providers managing clients with thrombotic disorders. Recognizing the specific agents used in different scenarios, such as in clients with HIT, ensures appropriate and effective treatment strategies are implemented to prevent further complications. Argatroban's unique mechanism of action and suitability for clients with HIT make it a key medication to be aware of in hematological practice.